Report Detail

Request for Sample of this report

Pharma & Healthcare Global Antimicrobial Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4618402
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
According to our (Global Info Research) latest study, the global Antimicrobial Peptides market size was valued at US$ 5.4 million in 2023 and is forecast to a readjusted size of USD 7.8 million by 2030 with a CAGR of 5.3% during review period.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report is a detailed and comprehensive analysis for global Antimicrobial Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Antimicrobial Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030
Global Antimicrobial Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030
Global Antimicrobial Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Mg), and average selling prices (US$/Mg), 2019-2030
Global Antimicrobial Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Mg), and ASP (US$/Mg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antimicrobial Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antimicrobial Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antimicrobial Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Market segment by Application
Pharmaceuticals
Feed Additives
Others
Major players covered
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antimicrobial Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antimicrobial Peptides, with price, sales quantity, revenue, and global market share of Antimicrobial Peptides from 2019 to 2024.
Chapter 3, the Antimicrobial Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antimicrobial Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Antimicrobial Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antimicrobial Peptides.
Chapter 14 and 15, to describe Antimicrobial Peptides sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antimicrobial Peptides Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Plant Antimicrobial Peptides
    • 1.3.3 Microbial Antimicrobial Peptides
    • 1.3.4 Animal Antimicrobial Peptides
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antimicrobial Peptides Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceuticals
    • 1.4.3 Feed Additives
    • 1.4.4 Others
  • 1.5 Global Antimicrobial Peptides Market Size & Forecast
    • 1.5.1 Global Antimicrobial Peptides Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Antimicrobial Peptides Sales Quantity (2019-2030)
    • 1.5.3 Global Antimicrobial Peptides Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 AnaSpec
    • 2.1.1 AnaSpec Details
    • 2.1.2 AnaSpec Major Business
    • 2.1.3 AnaSpec Antimicrobial Peptides Product and Services
    • 2.1.4 AnaSpec Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AnaSpec Recent Developments/Updates
  • 2.2 AMP Biotech
    • 2.2.1 AMP Biotech Details
    • 2.2.2 AMP Biotech Major Business
    • 2.2.3 AMP Biotech Antimicrobial Peptides Product and Services
    • 2.2.4 AMP Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AMP Biotech Recent Developments/Updates
  • 2.3 Phoenix Biotech
    • 2.3.1 Phoenix Biotech Details
    • 2.3.2 Phoenix Biotech Major Business
    • 2.3.3 Phoenix Biotech Antimicrobial Peptides Product and Services
    • 2.3.4 Phoenix Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Phoenix Biotech Recent Developments/Updates
  • 2.4 Novabiotics
    • 2.4.1 Novabiotics Details
    • 2.4.2 Novabiotics Major Business
    • 2.4.3 Novabiotics Antimicrobial Peptides Product and Services
    • 2.4.4 Novabiotics Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novabiotics Recent Developments/Updates
  • 2.5 Chinese Peptide
    • 2.5.1 Chinese Peptide Details
    • 2.5.2 Chinese Peptide Major Business
    • 2.5.3 Chinese Peptide Antimicrobial Peptides Product and Services
    • 2.5.4 Chinese Peptide Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Chinese Peptide Recent Developments/Updates
  • 2.6 Ontores
    • 2.6.1 Ontores Details
    • 2.6.2 Ontores Major Business
    • 2.6.3 Ontores Antimicrobial Peptides Product and Services
    • 2.6.4 Ontores Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ontores Recent Developments/Updates
  • 2.7 GenScript
    • 2.7.1 GenScript Details
    • 2.7.2 GenScript Major Business
    • 2.7.3 GenScript Antimicrobial Peptides Product and Services
    • 2.7.4 GenScript Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 GenScript Recent Developments/Updates
  • 2.8 Hycult Biotech
    • 2.8.1 Hycult Biotech Details
    • 2.8.2 Hycult Biotech Major Business
    • 2.8.3 Hycult Biotech Antimicrobial Peptides Product and Services
    • 2.8.4 Hycult Biotech Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Hycult Biotech Recent Developments/Updates
  • 2.9 Sunsmile
    • 2.9.1 Sunsmile Details
    • 2.9.2 Sunsmile Major Business
    • 2.9.3 Sunsmile Antimicrobial Peptides Product and Services
    • 2.9.4 Sunsmile Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sunsmile Recent Developments/Updates
  • 2.10 Ruixing Biotechnology
    • 2.10.1 Ruixing Biotechnology Details
    • 2.10.2 Ruixing Biotechnology Major Business
    • 2.10.3 Ruixing Biotechnology Antimicrobial Peptides Product and Services
    • 2.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Ruixing Biotechnology Recent Developments/Updates
  • 2.11 Zhongnong Yingtai Biotechnology
    • 2.11.1 Zhongnong Yingtai Biotechnology Details
    • 2.11.2 Zhongnong Yingtai Biotechnology Major Business
    • 2.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product and Services
    • 2.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Zhongnong Yingtai Biotechnology Recent Developments/Updates
  • 2.12 Glam Technology
    • 2.12.1 Glam Technology Details
    • 2.12.2 Glam Technology Major Business
    • 2.12.3 Glam Technology Antimicrobial Peptides Product and Services
    • 2.12.4 Glam Technology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Glam Technology Recent Developments/Updates
  • 2.13 ProteLight Pharmaceutical & Biotechnology
    • 2.13.1 ProteLight Pharmaceutical & Biotechnology Details
    • 2.13.2 ProteLight Pharmaceutical & Biotechnology Major Business
    • 2.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product and Services
    • 2.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates

3 Competitive Environment: Antimicrobial Peptides by Manufacturer

  • 3.1 Global Antimicrobial Peptides Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Antimicrobial Peptides Revenue by Manufacturer (2019-2024)
  • 3.3 Global Antimicrobial Peptides Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Antimicrobial Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Antimicrobial Peptides Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Antimicrobial Peptides Manufacturer Market Share in 2023
  • 3.5 Antimicrobial Peptides Market: Overall Company Footprint Analysis
    • 3.5.1 Antimicrobial Peptides Market: Region Footprint
    • 3.5.2 Antimicrobial Peptides Market: Company Product Type Footprint
    • 3.5.3 Antimicrobial Peptides Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antimicrobial Peptides Market Size by Region
    • 4.1.1 Global Antimicrobial Peptides Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Antimicrobial Peptides Consumption Value by Region (2019-2030)
    • 4.1.3 Global Antimicrobial Peptides Average Price by Region (2019-2030)
  • 4.2 North America Antimicrobial Peptides Consumption Value (2019-2030)
  • 4.3 Europe Antimicrobial Peptides Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Antimicrobial Peptides Consumption Value (2019-2030)
  • 4.5 South America Antimicrobial Peptides Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Antimicrobial Peptides Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 5.2 Global Antimicrobial Peptides Consumption Value by Type (2019-2030)
  • 5.3 Global Antimicrobial Peptides Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 6.2 Global Antimicrobial Peptides Consumption Value by Application (2019-2030)
  • 6.3 Global Antimicrobial Peptides Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 7.2 North America Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 7.3 North America Antimicrobial Peptides Market Size by Country
    • 7.3.1 North America Antimicrobial Peptides Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Antimicrobial Peptides Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 8.2 Europe Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 8.3 Europe Antimicrobial Peptides Market Size by Country
    • 8.3.1 Europe Antimicrobial Peptides Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Antimicrobial Peptides Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Antimicrobial Peptides Market Size by Region
    • 9.3.1 Asia-Pacific Antimicrobial Peptides Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Antimicrobial Peptides Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 10.2 South America Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 10.3 South America Antimicrobial Peptides Market Size by Country
    • 10.3.1 South America Antimicrobial Peptides Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Antimicrobial Peptides Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Antimicrobial Peptides Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Antimicrobial Peptides Market Size by Country
    • 11.3.1 Middle East & Africa Antimicrobial Peptides Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Antimicrobial Peptides Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Antimicrobial Peptides Market Drivers
  • 12.2 Antimicrobial Peptides Market Restraints
  • 12.3 Antimicrobial Peptides Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antimicrobial Peptides and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antimicrobial Peptides
  • 13.3 Antimicrobial Peptides Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antimicrobial Peptides Typical Distributors
  • 14.3 Antimicrobial Peptides Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antimicrobial Peptides. Industry analysis & Market Report on Antimicrobial Peptides is a syndicated market report, published as Global Antimicrobial Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Antimicrobial Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,599.56
    		3,899.34
    		5,199.12
    		3,118.08
    		4,677.12
    		6,236.16
    		496,944.00
    		745,416.00
    		993,888.00
    		291,310.80
    		436,966.20
    		582,621.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo